Unique Ownership Structure

Meet our largest shareholder: The Lundbeck Foundation

The Lundbeck Foundation is one of Denmark’s largest commercial foundations and Lundbeck’s largest shareholder – owning 70 percent of the company. The Lundbeck Foundation annually invests nearly $100 million in biomedical sciences research, primarily in the field of brain research. Our unique Foundation-ownership model distinguishes us from other pharmaceutical companies and binds our corporate purpose to brain research.

Each year, the Lundbeck Foundation awards the €1 million Brain Prize. It is the world’s largest brain research prize and is awarded to scientists who have made an outstanding contribution to neuroscience. Past Brain Prize winners include researchers who revolutionized our understanding of the genetic and molecular basis of Alzheimer’s disease; neuroscientists who pioneered the study of memories; and inventors of a transformative two-photon microscopy that dramatically changed how we study the brain.

Learn more about the 2018 Brain Prize winners

Learn more about past Brain Prize winners

In the Newsroom

Doug Williamson, MD, Chief Medical Officer & VP US Medical, shares how Lundbeck is building on the breakthroughs of the Brain Prize winners in our fight against Alzheimer’s.

Read more.

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck.